An oncolytic herpes simplex virus armed with IL-12 for treatment of preclinical glioblastoma. [PDF]
Jackson JW +13 more
europepmc +1 more source
Retraction for Kundu et al., Selective neutralization of IL-12 p40 monomer induces death in prostate cancer cells via IL-12-IFN-γ. [PDF]
europepmc +1 more source
Assessment of Fecal Microbiota in Healthy Dogs and Dogs with Cutaneous Mast Cell Tumors Treated with Electrochemotherapy Combined with Gene Electrotransfer of IL-12. [PDF]
Lisjak A +6 more
europepmc +1 more source
De-coupling immune parameters and toxicity associated with IL-12 agonism. [PDF]
Lanzar ZR +12 more
europepmc +1 more source
IL-12-armed oncolytic HSV-2 enhances CAR T cell efficacy against pancreatic cancer in xenografted models. [PDF]
Xu C +13 more
europepmc +1 more source
Intratumoral delivery of 4-1BBL boosts IL-12-triggered anti-glioma immunity. [PDF]
Lunavat TR +23 more
europepmc +1 more source
The Role and Potential Application of IL-12 in the Immune Regulation of Tuberculosis. [PDF]
Wang H, Ruan G, Li Y, Liu X.
europepmc +1 more source
Related searches:
IL-12 ELISPOT ASSAYS TO DETECT AND ENUMERATE IL-12 SECRETING CELLS
Cytokine, 2000The cytokine IL-12 promotes Th(1)type immune responses and plays a key role in immune regulation. The complex nature of IL-12 hampered its detection without use of stimulants that might give less relevant information. To detect circulating IL-12 p40, we developed enzyme-linked immunospot (ELISPOT) assays that allow enumeration of IL-12 p40 secreting ...
Ozenci, V +4 more
openaire +3 more sources
Interleukin(IL)-12 is a protein that activates T cells and macrophages to kill tumor cells. However, despite this cytokine showing strong antitumor activity in preclinical settings, translation to patients has been slowed by toxic side effects, poor distribution to peripheral tissues, and improper dosing regimens.
Justin E, Markel +2 more
openaire +2 more sources
Delivery of IL-12 intranasally leads to reduced IL-12-mediated toxicity
International Immunopharmacology, 2003Interleukin-12 (IL-12) is a heterodimeric cytokine that enhances immune responses to bacterial, parasitic, and viral pathogens, and leads to tumor regression in animal models. For this reason, the use of IL-12 as a vaccine adjuvant and as a therapeutic agent for the treatment of cancer is being investigated.
Victor C, Huber +6 more
openaire +2 more sources

